Radiation Oncology

Yusung Kim, PhD


Assistant Professor of Radiation Oncology

Contact Information

Phone: +319-384-9406

Email: yusung-kim@uiowa.edu


BS, Nuclear Engineering, Hanyang University, Rep. of Korea (South)
MS, Medical Physics, University of Wisconsin, Madison, WI
PhD, Medical Physics, University of Wisconsin, Madison, WI

Licensure and Certifications

American Board of Radiology in Therapeutic Radiological Physics, American Board of Radiology

All Publications

Dou X, Kim Y, Bayouth J, Buatti J, Wu X.  Optimal field-splitting algorithm in intensity-modulated radiotherapy: Evaluations using head-and-neck and female pelvic IMRT cases.  Medical Dosimetry.  2013 2nd Quarter. 38(1):12-17.

Anderson J, Huang Y, Kim Y.  Dosimetric impact of point A definition on high-dose-rate brachytherapy for cervical cancer: evaluations on conventional point A and MRI-guided, conformal plans.  Journal of Contemporary Brachytherapy.  2012 December. 4(4):241-246.

Hyer D, Sheybani A, Jacobson G, Kim Y.  The dosimetric impact of heterogeneity corrections in high dose rate brachytherapy for cervical cancer: investigation of both conventional Point-A and volume-optimized tandem-and-ovoid plans.  Brachytherapy.  2012 November. 11(6):515-520.

Flynn R, Kim Y, Jacobson G.  Compensator-based intensity modulated brachytherapy for cervical cancer.  Medical Physics.  2012. 

Schindel J, Zhang W, Kim Y.  Evaluations on Applicator Displacements for Cervical Cancer Brachytherapy due to Additional Scan for 3D Image Guidance.  Practical Radiation Therapy.  2012. 

Anderson J, Xia J, Flynn R, Modrick  J, Bhatia S, Jacobson G, Kim Y.  High Resolution (3 Tesla) MRI-Guided, Conformal Brachytherapy for Cervical Cancer: Consequences of Different High-Risk CTV (Clinical Target Volume) Sizes.  Practical Radiation Therapy.  2012. 

Schindel J, Muruganandham M, Pigge F, Kim Y.  MRI Markers for MRI-Guided HDR Brachytherapy: Marker-Flange for Cervical Cancer and Marker-Catheters for Prostate Cancer.  International Journal of Radiation Oncology, Biology, Physics.  2012. 

Liu Y, Flynn R, Kim Y, Wu X.  Optimal sequencing in Rotating-shield Intensity-Modulated Brachytehrapy.  Medical Physics.  2012. 

Sun W, Bhatia S, Jacobson G, Flynn R, Kim Y.  The Changes of Target Volumes Through High Dose Rate Brachytherapy for Cervical Cancer When evaluated on High Resolution (3.0 Telsa) MRI.  Practical Radiation Oncology (PRO);  2012. 

Rockey W, Bhatia S, Jacobson G, Kim Y.  The dosimetric impact of Vaginal Balloon-Packing on Intracavitary High Dose Rate Brachytherapy for Gynecological Cancer.  Brachytherapy.  2012. 

Siochi R, Kim Y, Bhatia S.  Tumor Control Probability Reduction in Phase Gated RT Treatments of Non-Small-Cell Lung Cancer Tumors with Motion in Excess of Planned Motion.  Journal of Applied Clinical Medical Physics.  2012. 

Kim Y, Muruganandham M, Modrick J, Bayouth J.  Evaluation of artifacts and distortions of titanium applicators on 3.0-Tesla MRI: feasibility of titanium applicators in MRI-guided brachytherapy for gynecological cancer.  International Journal of Radiation Oncology, Biology, Physics.  2011 July. 80(3):947-955.

Kim Y, Tome W.  Dose-Painting IMRT Optimization using Biological Parameters.  Acta Oncologica (Sweden).  2010 November. 49(8):1374-1384.

Kim Y, Tome W.  The impact of function imaging accuracy (sensitivity and specificity) for high-risk tumor subvolumes on a selective boosting IMRT.  Physica Medica.  2009. 25(12):24.

Kim Y, Tome W.  Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans.  Acta Oncologica (Sweden).  2008. 47(5):906-916.

Kim Y, Tome W.  On Voxel Based Iso-Tumor Control Probability and Iso-Complication Maps for Selective Boosting and Selective Avoidance Intensity-Modulated Radiotherapy.  Imaging Decisions (Germany).  2008. 12(1):42-50.

Kim Y, Tome W.  On the radiobiological impact of metal artifacts in head-and-neck IMRT in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).  Medical & Biological Engineering & Computing.  2007 November. 45(11):1045-1051.

Kim Y, Tome W.  Optimization of Radiotherapy Using Biological Parameters.  New York: Springer.  2007. 

Kim Y, Tome W.  Risk-adaptive optimization: selective boosting of high-risk tumor subvolumes.  International Journal of Radiation Oncology, Biology, Physics.  2006 December. 66(5):1528-1542.

Kim Y, Tome W, Bal M, McNutt T, Spies L.  The impact of dental metal artifacts on head and neck IMRT dose distributions.  Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology.  2006 May. 79(2):198-202.

Kim Y, Tome W.  The impact of metal artifacts on IMRT dose distributions in TCP and NTCP.  2006. 2:1635-1638.

Yang W, Kim Y, Wu X, Song Q, Flynn R.  Rotating-shield intensity modulated brachytherapy (RS-IMBT) for Cervical Cancer.  Journal of Radiotherapy Oncology. 

Date Last Modified: 06/06/2016 - 13:17:48